Dear Reader

As we reach the final issue of Pediatric Drugs for 2013, we hope that you have found the articles published throughout the year to be interesting and informative. The editors and publishing staff have appreciated the high quality of content contributed to the journal this year. The publishing schedule for 2014 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.

The quality of articles published in Pediatric Drugs was acknowledged in the new Impact Factor for 2012, which increased by 5.5 % to 1.884. The journal is now placed 43rd out of 121 in the Pediatrics category. The Adis portfolio as a whole saw impressive Impact Factor gains, with flagship journals continuing to increase their citations – Drugs raised its Impact Factor to 4.633, with Clinical Pharmacokinetics and Sports Medicine also seeing significant rises to 6.109 and 5.237, respectively. Pharmacoeconomics remains the number one journal in its field, and The Patient: Patient-Centered Outcomes Research saw an increase of more than 170% in its Impact Factor to 1.565, only one year after first appearing in the Journal Citation Reports®.

2013 saw the successful integration of the Adis portfolio of journals into the Springer production systems and custom-built platforms (SpringerLink, Springer for R&D, and Springer for Hospitals & Health). We are confident that our authors and subscribers benefit from improved discoverability, mobile optimisation and robust delivery of content on these platforms; and Springer production capacity has allowed us to increase the number of articles published whilst considerably reducing submission-to-publication times across the portfolio.

Looking ahead to 2014, the Adis portfolio will continue to grow the amount of content published while maintaining high standards. The number of Adis titles will also increase as existing quality Springer journals are brought under the Adis brand - Advances in Therapy, Targeted Oncology, and the European Journal of Drug Metabolism and Pharmacokinetics. Adis are also committed to fostering Open Access publication: all Adis titles offer the Springer Open Choice option and we are adding a further 10 fully Open Access titles in specific therapy areas such as Diabetes Therapy, Cardiology and Therapy and Dermatology and Therapy, previously published under the Springer Healthcare imprint. Information about the portfolio can be found on Springer.com/Adis.

We would like to thank all the authors who have contributed articles to Pediatric Drugs in the last 12 months. They have generously set aside time in their busy schedules to prepare content, and without their hard work and diligence we would not have been able to publish the journal. The quality of published articles also reflects the significant time and effort dedicated by the peer reviewers, who ensure that we continue to publish content of the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals who acted as referees for articles in Pediatric Drugs in 2013:

Ishaq Abu-Arafeh, UK

Karel Allegaert, Belgium

Margarida Amaral, Portugal

Ann L. Anderson-Berry, USA

Adriano Arguedas, Costa Rica

Surabhi Batra, USA

Frederic Becq, France

M.L. Bernstein, Canada

Emma Best, New Zealand

Timothy G. Beukelman, USA

Deepak Bhatnagar, UK

Udo Bode, Germany

David A. Brent, USA

Davide Caimmi, France

Misty Carlson, USA

John P. Clancy, USA

Antonio Clavenna, Italy

David R. Coghill, UK

Alessandro Consolaro, Italy

Shyamali C. Dharmage, Australia

Okan Elidemir, USA

Cristan Farmer, USA

Jeffrey A. Feinstein, USA

Yaron Finkelstein, Canada

Michael S. Freemark, USA

Robert Frenck Jr, USA

Giovanni Gabutti, Italy

C. Gambacorti-Passerini, Italy

Silvestre García-de-la-Puente, Mexico

Madlen Gazarian, Australia

Vania Giacomet, Italy

Robert D. Goldney, Australia

J. Grill, France

Andreas H. Groll, Germany

Philip Hazell, Australia

Peter Hopkins, Australia

Kalle Hoppu, Finland

Hiroto Inaba, USA

Lorenzo Iughetti, Italy

Ignacio Jauregui, Spain

D.L. Johnston, Canada

Stephen F. Kemp, USA

Naomi Kondo, Japan

Mario La Rosa, Italy

Lucia Lee, USA

Hoan Jong Lee, Republic of Korea

Agustin Legido, USA

Kathryn Love-Osborne, USA

Marina Macchiaiolo, Italy

Maura Massimino, Italy

Sebastiano Mercadante, Italy

Kirsten Minden, Germany

Shahin Moledina, UK

Dezhi Mu, China

Sharon S.A. Nachman, USA

Roland Neumann, Switzerland

Leiv Ose, Norway

Hasan H. Ozkan, Turkey

Nikolaos G. Papadopoulos, Greece

Roman Prymula, Czech Republic

Pierre Quartier, France

C.E. Rabinovich, USA

Y. Ravindranath, USA

Michael D. Reed, USA

Stefan Rose-John, Germany

Jean-Claude Roujeau, France

Antonio Ruggiero, Italy

Ricardo A. Russo, Argentina

Gabriella Silver, USA

F. Sim, USA

Arjen J.C. Slooter, Netherlands

B. Stone, USA

Nikhil Tandon, India

Yong-Kwang Tay, Singapore

Susan B. Turkel, USA

Wendy J. Ungar, Canada

Hendrik van den Berg, Netherlands

Marcel P.H. van den Broek, Netherlands

Stijn E. Verleden, Belgium

Benedetto Vitiello, USA

Catherine Weil-Olivier, France

Johannes E. Wolff, USA

Shumpei Yokota, Japan

Christian Michel Zwaan, Netherlands

Along with our schedule of invited articles, we also encourage the submission of high-quality reviews and original research articles. We would like to remind to you keep Pediatric Drugs in mind when deciding where to submit your research. We also welcome comment from our readers on any of our articles.

We look forward to your continued support of the journal in 2014 and to bringing you first-class content from around the globe. With best wishes from the staff of Pediatric Drugs and all at Adis Publications.